Caxton Associates LP Ptc Therapeutics, Inc. Transaction History
Caxton Associates LP
- $2.65 Billion
- Q3 2024
Shares
2 transactions
Others Institutions Holding PTCT
# of Institutions
221Shares Held
78.1MCall Options Held
144KPut Options Held
58.7K-
Vanguard Group Inc Valley Forge, PA9.13MShares$419 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA7.89MShares$362 Million0.05% of portfolio
-
Black Rock Inc. New York, NY7.77MShares$357 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.39MShares$339 Million4.37% of portfolio
-
Armistice Capital, LLC New York, NY7.23MShares$332 Million4.46% of portfolio
About PTC THERAPEUTICS, INC.
- Ticker PTCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,541,000
- Market Cap $3.28B
- Description
- PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...